Clinical Trial Update: EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS) [Phase 3]

View source ↗

Summary

Phase 3 EURIDIS trial evaluating dronedarone for maintenance of sinus rhythm in patients with atrial fibrillation or atrial flutter has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Multaq (dronedarone)

Snippet

Sponsor: Sanofi | Conditions: Atrial Fibrillation, Atrial Flutter | Phase 3 | Status: COMPLETED